Printed from https://ideas.repec.org/s/wly/hlthec15.html
Content
March 2003, Volume 12, Issue 3
- 171-186 An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population
by Jack Hadley & Daniel Polsky & Jeanne S. Mandelblatt & Jean M. Mitchell & Jane C. Weeks & Qin Wang & Yi‐Ting Hwang & OPTIONS Research Team - 187-198 Preferences and person trade‐offs: forcing consistency or inconsistency in health‐related quality of life measures?
by Edward C. Mansley & Elamin H. Elbasha - 199-215 The interaction between cost‐management and learning for major surgical procedures – lessons from asymmetric information
by Christian M. Ernst - 217-230 The effect of cigarette prices on youth smoking
by Hana Ross & Frank J. Chaloupka - 231-246 Medical care use and selection in a social health insurance with an equalization fund: evidence from Colombia
by Antonio J. Trujillo - 247-250 A note on cost‐value analysis
by Lars Peter Østerdal - 251-253 Comments to ‘a note on cost‐value analysis’
by Erik Nord & José Luis Pinto & Jeff Richardson & Paul Menzel & Peter Ubel
February 2003, Volume 12, Issue 2
- 87-100 A cost‐minimisation study of alternative discharge policies after hip fracture repair
by Johan J. Polder & Romke van Balen & Ewout W. Steyerberg & Herman J.M. Cools & J. Dik F. Habbema - 101-112 Medical student indebtedness and the propensity to enter academic medicine
by Marc Fox - 113-124 The determinants of health care expenditure: testing pooling restrictions in small samples
by Helmut Herwartz & Bernd Theilen - 125-138 Deadweight loss of bacterial resistance due to overtreatment
by Elamin H. Elbasha - 139-148 How measures of perception from survey data lead to inconsistent regression results: evidence from adolescent and peer substance use
by Edward C. Norton & Richard C. Lindrooth & Susan T. Ennett - 149-158 Managed care and technical efficiency
by H. Shelton Brown - 159-162 Determining the optimal combinations of mutually exclusive interventions: a response to Hutubessy and colleagues
by Douglas Coyle - 163-164 Formal response to ‘Determining the optimal combinations of mutually exclusive interventions: a response to Hutubessy and colleagues’
by Rob M.P.M. Baltussen & Raymond C.W. Hutubessy & Jan J. Barendregt & David B. Evans & Christopher J.L. Murray - 165-169 Double discounting of QALYs
by Linda D. MacKeigan & Amiram Gafni & Bernie J. O'Brien
January 2003, Volume 12, Issue 1
- 1-2 Announcement and Editorial
by John Hutton & Andrew Jones & Alan Maynard - 3-16 Estimating the monetary value of health care: lessons from environmental economics
by Nick Hanley & Mandy Ryan & Robert Wright - 17-31 A utility‐theoretic model for QALYs and willingness to pay
by Thomas Klose - 33-49 Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?
by Anthony O'Hagan & John W. Stevens - 51-64 Eliciting several willingness to pay in a single contingent valuation survey: application to health care
by Stéphane Luchini & Christel Protière & Jean‐Paul Moatti - 65-66 Comment on Amartya Sen's ‘why health equity’
by Alan Williams - 67-73 How important are economic factors in choice of medical specialty?
by James Thornton & Fred Esposto - 75-76 Book Review
by John Appleby
December 2002, Volume 11, Issue 8
- 659-666 Why health equity?
by Amartya Sen - 667-677 Reducing avoidable inequalities in health: a new criterion for setting health care capitation payments
by Katharina Hauck & Rebecca Shaw & Peter C. Smith - 679-693 QALY‐maximisation and public preferences: results from a general population survey
by Stirling Bryan & Tracy Roberts & Chris Heginbotham & Alison McCallum - 695-708 A theoretical model of adolescent suicide and some evidence from US data
by Vijay K. Mathur & Donald G. Freeman - 709-722 The subjective costs of health losses due to chronic diseases. An alternative model for monetary appraisal
by Ada Ferrer‐i‐Carbonell & Bernard M.S. van Praag - 723-734 The importance of being first: evidence from Canadian generic pharmaceuticals
by Aidan Hollis - 735-739 Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods
by Nicholas Graves & Damian Walker & Rosalind Raine & Andrew Hutchings & Jennifer A. Roberts
October 2002, Volume 11, Issue 7
- 571-584 Do competition and managed care improve quality?
by Nazmi Sari - 585-598 Revealed preference valuation compared to contingent valuation: radon‐induced lung cancer prevention
by Christine A. Kennedy - 599-622 A comparison of consensus and nonconsensus approaches to modeling contraceptive choice behavior
by Li‐Wei Chao - 623-635 Willingness to pay for health risk reduction in the context of altruism
by Jorge E. Araña & Carmelo J. León - 637-647 Superbugs II: how should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance?
by Joanna Coast & Richard Smith & Anne‐Marie Karcher & Paula Wilton & Michael Millar - 649-651 Recognising diversity in public preferences: the use of preference sub‐groups in cost‐effectiveness analysis. A response to Sculpher and Gafni
by Angela Robinson & David Parkin - 653-654 Recognising diversity in public preferences: the use of preference sub‐groups in cost‐effectiveness analysis. Authors' reply
by Mark Sculpher & Amiram Gafni - 655-658 Decision making heuristics and the elicitation of preferences: being fast and frugal about the future
by John Cairns & Marjon van der Pol & Andrew Lloyd
September 2002, Volume 11, Issue 6
- 469-470 Guest Editors' Introduction
by Andrew Jones & Owen O'Donnell - 471-483 Disentangling the effects of morbidity and life expectancy on labor market outcomes
by M. Christopher Auld - 485-491 Rational addiction to alcohol: panel data analysis of liquor consumption
by Badi H. Baltagi & James M. Griffin - 493-503 Keeping nurses at work: a duration analysis
by Tor Helge Holmås - 505-520 An econometric analysis of the mental‐health effects of major events in the life of older individuals
by Maarten Lindeboom & France Portrait & Gerard J. van den Berg - 521-535 How important are tobacco prices in the propensity to start and quit smoking? An analysis of smoking histories from the Spanish National Health Survey
by Angel López Nicolás - 537-549 Vertical and horizontal aspects of socio‐economic inequity in general practitioner contacts in Scotland
by Matthew Sutton - 551-566 Bayesian estimation, simulation and uncertainty analysis: the cost‐effectiveness of ganciclovir prophylaxis in liver transplantation
by David J. Vanness & W. Ray Kim - 567-568 The Purchasing of Health Care by Primary Care Organisations. An evaluation and Guide to Future Policy, by N. Mays, S. Wyke, G. Malbon, N. Goodwin. Open University Press, Buckingham and Philadelphia, 2001. No. of pages: 320. ISBN 0‐335‐20900‐9
by Nancy J. Devlin
July 2002, Volume 11, Issue 5
- 377-387 Does prospective payment reduce inpatient length of stay?
by Edward C. Norton & Courtney Harold Van Houtven & Richard C. Lindrooth & Sharon‐Lise T. Normand & Barbara Dickey - 389-402 The benefits of switching smoking cessation drugs to over‐the‐counter status
by Theodore E. Keeler & Teh‐wei Hu & Alison Keith & Richard Manning & Martin D. Marciniak & Michael Ong & Hai‐Yen Sung - 403-413 The impact of diabetes on adult employment and earnings of Mexican Americans: Findings from a community based study
by Elena Bastida & José A. Pagán - 415-430 Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis
by Jeffrey S. Hoch & Andrew H. Briggs & Andrew R. Willan - 431-446 Social risk management options for medical care in Indonesia
by Menno Pradhan & Nicholas Prescott - 447-456 A new explanation for the difference between time trade‐off utilities and standard gamble utilities
by Han Bleichrodt - 457-465 Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination
by Jane Hall & Patricia Kenny & Madeleine King & Jordan Louviere & Rosalie Viney & Angela Yeoh - 467-468 Health economics resources ‐ an update
by Bruce Hollingsworth
June 2002, Volume 11, Issue 4
- 285-299 Prenatal screening for cystic fibrosis: an economic analysis
by Randi Nielsen & Dorte Gyrd‐Hansen - 301-321 Latent class versus two‐part models in the demand for physician services across the European Union
by Sergi Jiménez‐Martín & José M. Labeaga & Maite Martínez‐Granado - 323-340 Do Medicare HMOs still reduce health services use after controlling for selection bias?
by Michelle M. Mello & Sally C. Stearns & Edward C. Norton - 341-353 Estimating an EQ‐5D population value set: the case of Japan
by Aki Tsuchiya & Shunya Ikeda & Naoki Ikegami & Shuzo Nishimura & Ikuro Sakai & Takashi Fukuda & Chisato Hamashima & Akinori Hisashige & Makoto Tamura - 355-370 Discounting and clinical decision making: Physicians, patients, the general public, and the management of asymptomatic abdominal aortic aneurysms
by S. Höjgård & U. Enemark & C. H. Lyttkens & A. Lindgren & T. Troëng & H. Weibull - 371-376 Unit root properties of OECD health care expenditure and GDP data
by Garry MacDonald & Sandra Hopkins
April 2002, Volume 11, Issue 3
- 185-191 On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales
by Stephen Birch & Amiram Gafni - 193-206 Neonatal health care costs related to smoking during pregnancy
by E. Kathleen Adams & Vincent P. Miller & Carla Ernst & Brenda K. Nishimura & Cathy Melvin & Robert Merritt - 207-220 On the empirical association between poor health and low socioeconomic status at old age
by Christian Salas - 221-231 A general model of the impact of absenteeism on employers and employees
by Mark V. Pauly & Sean Nicholson & Judy Xu & Dan Polsky & Patricia M. Danzon & James F. Murray & Marc L. Berger - 233-248 Estimating survival gain for economic evaluations with survival time as principal endpoint: A cost‐effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer
by N. Neymark & I. Adriaenssen & T. Gorlia & S. Caleo & M. Bolla - 249-264 Statistical determination of cost‐effectiveness frontier based on net health benefits
by Eugene M. Laska & Morris Meisner & Carole Siegel & Joseph Wanderling - 265-273 Morality and the limits of societal values in health care allocation
by Rebecca L. Walker & Andrew W. Siegel - 275-280 The familywise error rate of a simultaneous confidence band for the incremental net health benefit
by Morris Meisner & Eugene M. Laska & Carole Siegel & Joseph Wanderling - 281-284 The European Union and Health Policy, by Ed Randall. Palgrave, Hampshire and New York, 2001. No. of pages: xiii+278. ISBN 0‐333‐75426‐3.. The Implications of Recent Jurisprudence on the Co‐ordination of Health Care Protection Systems, by Willy Palm, Jason Nickless, Henri Lewalle and Alain Coheur. Association Internationale de la Mutualite, Brussess, 2000. No. of pages: 170. [http://europa.eu.int/comm/employment_social/soc‐prot/disable/report.pdf]. Health Care Without Frontiers? The Development of a European Market in Health Services by Lyndsay Mountford. Office of Health Econ‐omics, London, 2000. No. of pages: 83. ISBN 1‐899040‐71‐4
by Elias Mossialos
March 2002, Volume 11, Issue 2
- 93-101 The World Health Report 2000: dialogue of the deaf?
by Kjeld Møller Pedersen - 103-115 Reflections on and alternatives to WHO's fairness of financial contribution index
by Adam Wagstaff - 117-127 Testing the convergent validity of the contingent valuation and travel cost methods in valuing the benefits of health care
by Philip M. Clarke - 129-139 Measuring willingness‐to‐pay for risk reduction: an application of conjoint analysis
by Harry Telser & Peter Zweifel - 141-154 Socio‐economic health inequalities in Brazil: gender and age effects
by M. Dolores Montoya Diaz - 155-163 Obtaining disability weights in rural Burkina Faso using a culturally adapted visual analogue scale
by R.M.P.M. Baltussen & M. Sanon & J. Sommerfeld & R. Würthwein - 165-174 How profitable is risk selection? A comparison of four risk adjustment models
by Yujing Shen & Randall P. Ellis - 175-180 Is there a kink in consumers' threshold value for cost‐effectiveness in health care?
by Bernie J. O'Brien & Kirsten Gertsen & Andrew R. Willan & A. Faulkner - 181-181 Health Economics for Developing Countries. A Practical Guide, by S. Witter, T. Ensor, M. Jowett and R. Thompson. MacMillan Education, London, 2000. No. of pages: 296. ISBN 0‐333‐75205‐8
by Stephen Jan - 182-182 User Fees for Health Services: Guidelines for Protecting the Poor, by William Newbrander, David Collins and Lucy Gilson. Management Sciences for Health, Boston, 2001. No. of pages: 74. ISBN 0‐913‐723‐80‐0.. Ensuring Equal Access to Health Services: User fee Systems and the Poor, by William Newbrander, David Collins and Lucy Gilson. Management Sciences for Health, Boston, 2001. No. of pages: 200. ISBN 0‐913‐723‐79‐7
by Sophie Witter
January 2002, Volume 11, Issue 1
- 1-8 Decision validity should determine whether a generic or condition‐specific HRQOL measure is used in health care decisions
by Jack Dowie - 9-12 Commentary on Jack Dowie, “Decision validity should determine whether a generic or condition‐specific HRQOL measure is used in health care decisions”
by Gordon Guyatt - 13-16 Commentary on Jack Dowie, “Decision validity should determine whether a generic or condition‐specific HRQOL measure is used in health care decisions”
by David Feeny - 17-19 Measures of health‐related quality of life in an imperfect world: a comment on Dowie
by John Brazier & Ray Fitzpatrick - 21-22 ‘Decision validity…’: A rejoinder
by Jack Dowie - 23-31 Opportunity costs and uncertainty in the economic evaluation of health care interventions
by P. Sendi & A. Gafni & S. Birch - 33-42 Estimation of the transition matrix of a discrete‐time Markov chain
by Bruce A. Craig & Peter P. Sendi - 43-53 Measuring the social importance of concentration or dispersion of individual health benefits
by Eva Rodríguez‐Míguez & José‐Luis Pinto‐Prades - 55-70 The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes
by Cam Donaldson & Stephen Birch & Amiram Gafni - 71-85 The practicality and validity of directly elicited and SF‐36 derived health state preferences in patients with low back pain
by William Hollingworth & Richard A. Deyo & Sean D. Sullivan & Scott S. Emerson & Darryl T. Gray & Jeffrey G. Jarvik - 87-88 Health economics: an evolving paradigm but sailing in the wrong direction? A view from the front line
by David Kernick
December 2001, Volume 10, Issue 8
- 683-698 How reliable are hospital efficiency estimates? Exploiting the dual to homothetic production
by Sherman T. Folland & Richard A. Hofler - 699-714 Family health effects: complements or substitutes
by Michael Lee Ganz - 715-729 Twenty years of health care economic analysis in Spain: are we doing well?
by Anna García‐Altés - 731-749 Changing the first line drug for malaria treatment—cost‐effectiveness analysis with highly uncertain inter‐temporal trade‐offs
by Catherine A. Goodman & Paul G. Coleman & Anne J. Mills - 751-774 Economic evaluations of hepatitis B immunization: a global review of recent studies (1994–2000)
by Philippe Beutels - 775-778 Methodological limitations of economic evaluations of antenatal screening
by Stavros Petrou - 779-787 Representing uncertainty: the role of cost‐effectiveness acceptability curves
by Elisabeth Fenwick & Karl Claxton & Mark Sculpher
October 2001, Volume 10, Issue 7
- 573-577 Should we aggregate relative or absolute changes in QALYs?
by Magnus Johannesson - 579-581 The desirability of a condition versus the well being and worth of a person
by Erik Nord - 583-585 The ‘fair innings argument’ deserves a fairer hearing! comments by Alan Williams on Nord and Johannesson
by Alan Williams - 587-599 Discounting for health effects in cost–benefit and cost‐effectiveness analysis
by Hugh Gravelle & Dave Smith - 601-615 The impact of non‐compliance on the cost‐effectiveness of pharmaceuticals: a review of the literature
by Dyfrig A. Hughes & Adrian Bagust & Alan Haycox & Tom Walley - 617-634 Analysing public preferences for cancer screening programmes
by Dorte Gyrd‐Hansen & Jes Søgaard - 635-649 Paradigms and research programmes: is it time to move from health care economics to health economics?
by Rhiannon Tudor Edwards - 651-668 The physician–patient relationship as a game of strategic information transmission
by Kris De Jaegher & Marc Jegers - 669-671 Econometric issues in testing the age neutrality of health care expenditure
by Christian Salas & James P. Raftery - 673-674 Reply to: econometric issues in testing the age neutrality of health care expenditure
by Peter Zweifel & Stefan Felder & Markus Meier - 675-680 Affordability and cost‐effectiveness: decision‐making on the cost‐effectiveness plane
by P. Pedram Sendi & Andrew H. Briggs - 681-682 Telemedicine and Telehealth: Principles, Policies, Performance and Pitfalls by Adam W. Darkins and Margaret A. Cary. Free Association Books, London, 2000. No. of pages 316. ISBN 1‐853‐43518‐X
by W. David Bradford - 682-682 Clinical Guidelines. From Conception to Use, edited by Martin Eccles and Jeremy Grimshaw. Radcliffe Medical Press, Oxford, UK, 2000. No. of pages: 120. ISBN 1‐85775‐426‐3
by Ian Watt
September 2001, Volume 10, Issue 6
- 479-486 The private finance initiative: a public finance illusion?
by Diane Dawson - 487-497 The relative sensitivity of willingness‐to‐pay and time‐trade‐off to changes in health status: an empirical investigation
by Richard D. Smith - 499-508 Cost‐effectiveness analysis with risk aversion
by Joshua Graff Zivin - 509-521 The impact of problem drinking on employment
by Weiwei Feng & Wei Zhou & J.S. Butler & Brenda M. Booth & Michael T. French - 523-538 Estimating hospital costs with a generalized Leontief function
by Tong Li & Robert Rosenman - 539-551 Cost efficiency of US hospitals: a stochastic frontier approach
by Michael D. Rosko - 553-564 Testing efficacy with detection controlled estimation: an application to telemedicine
by W. David Bradford & Andrew N. Kleit & M. A. Krousel‐Wood & Richard N. Re - 565-572 Equity in Swedish health care reconsidered: new results based on the finite mixture model
by Ulf‐G. Gerdtham & Pravin K. Trivedi
July 2001, Volume 10, Issue 5
- 369-370 Guest editors' introduction
by Andrew Jones & Owen O'Donnell - 371-383 A discrete random effects probit model with application to the demand for preventive care
by Partha Deb - 385-398 The performance of sample selection estimators to control for attrition bias
by Astrid Grasdal - 399-410 Estimating treatment effects in randomized clinical trials with non‐compliance: the impact of maternal smoking on birthweight
by Barton H. Hamilton - 411-428 Proportional treatment effects for count response panel data: effects of binary exercise on health care demand
by Myoung‐Jae Lee & Satoru Kobayashi - 429-440 Live long, live well: quantifying the health of heterogeneous populations
by John Mullahy - 441-456 The effect of variable health insurance deductibles on the demand for physician visits
by Martin Schellhorn - 457-471 Effects of cost sharing on physician utilization under favourable conditions for supplier‐induced demand
by Carine Van De Voorde & Eddy Van Doorslaer & Erik Schokkaert - 473-477 Stochastic league tables: communicating cost‐effectiveness results to decision‐makers
by Raymond C.W. Hutubessy & Rob M.P.M. Baltussen & David B. Evans & Jan J. Barendregt & Christopher J.L. Murray
June 2001, Volume 10, Issue 4
- 277-282 Science or marketing at who? A response to Williams
by Christopher J.L. Murray & Julio Frenk & David Evans & Kei Kawabata & Alan Lopez & Orvill Adams - 283-285 Science or marketing at who? Rejoinder from Alan Williams
by Alan Williams - 287-302 The role of permanent income and family structure in the determination of child health in Canada
by Lori J. Curtis & Martin D. Dooley & Ellen L. Lipman & David H. Feeny - 303-315 A framework for cost‐effectiveness analysis from clinical trial data
by Anthony O'Hagan & John W. Stevens - 317-324 Recognizing diversity in public preferences: The use of preference sub‐groups in cost‐effectiveness analysis
by Mark Sculpher & Amiram Gafni - 325-339 Provider payment reform in China: the case of hospital reimbursement in Hainan province
by Winnie Yip & Karen Eggleston - 341-350 The effect of health on acute care supplemental insurance ownership: an empirical analysis
by Amir Shmueli - 351-356 Private and social time preferences for health and money: an empirical estimation
by Angelina Lazaro & Ramon Barberan & Encarnacion Rubio - 357-361 The impact of income inequality on individual and societal health: absolute income, relative income and statistical artefacts
by John Wildman - 363-366 Cost prediction models for the comparison of two groups
by Andrew R. Willan & Bernie J. O'Brien - 367-368 The Economic Analysis of Substance Use and Abuse: An Integration of Econometric and Behavioral Economic Research edited by F.J. Chaloupka, M. Grossman, W.K. Bickel and H. Safer. University of Chicago Press, Chicago, 1999. No. of pages 383. ISBN 0‐226‐10047‐2
by Michael T. French - 368-368 The Politics of Emerging and Resurgent Infectious Diseases edited by Jim Whitman. Macmillan Press, Basingstoke, 2000. No. of pages 223. ISBN 0‐333‐69127‐X
by Tom Jefferson
April 2001, Volume 10, Issue 3
- 187-205 Equity considerations in health care: the relevance of claims
by Xavier Cuadras‐Morató & José‐Luis Pinto‐Prades & José‐María Abellán‐Perpiñán - 207-220 Targeted health insurance in a low income country and its impact on access and equity in access: Egypt's school health insurance
by Winnie Yip & Peter Berman - 221-232 Demand for traditional medicine in Taiwan: a mixed Gaussian–Poisson model approach
by Steven T. Yen & Chao‐Hsiun Tang & Shew‐Jiuan B. Su - 233-243 On the societal value of health care: what do we know about the person trade‐off technique?
by Colin Green - 245-256 The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study
by Ruth Etzioni & Scott D. Ramsey & Kristin Berry & Martin Brown - 257-270 Alcohol abuse and economic conditions: Evidence from repeated cross‐sections of individual‐level data
by Thomas S. Dee - 271-276 Reconsideration of discharge data to measure competition in the hospital industry
by Eric Nauenberg & Yuri Andrijuk & Matthew Eisinger
March 2001, Volume 10, Issue 2
- 93-100 Science or marketing at WHO? A commentary on ‘World Health 2000’
by Alan Williams - 101-118 Alternative approaches to obtain optimal bid values in contingent valuation studies and to model protest zeros. Estimating the determinants of individuals' willingness to pay for home care services in day case surgery
by Eulàlia Dalmau‐Matarrodona - 119-134 Strategic interaction among hospitals and nursing facilities: the efficiency effects of payment systems and vertical integration
by Dwayne Banks & Elliott Parker & Jeanne Wendel - 135-145 Health insurance and health services utilization in Ireland
by Colm Harmon & Brian Nolan - 147-158 Searching for a better willingness to pay elicitation method in rural Nigeria: the binary question with follow‐up method versus the bidding game technique
by Obinna Onwujekwe - 159-174 Citizens, their agents and health care rationing: an exploratory study using qualitative methods
by Joanna Coast - 175-177 Aging and health care expenditures: A comment on Zweifel, Felder and Meiers
by Thomas E. Getzen - 179-184 The death of cost‐minimization analysis?
by Andrew H. Briggs & Bernie J. O'Brien
January 2001, Volume 10, Issue 1
- 1-7 The world‐wide growth in obesity: an economic research agenda
by Tomas Philipson - 9-25 Physicians' payment contracts, treatment decisions and diagnosis accuracy
by Izabela Jelovac - 27-37 A comparison of scoring weights for the EuroQol© derived from patients and the general public
by Daniel Polsky & Richard J. Willke & Karen Scott & Kevin A. Schulman & Henry A. Glick - 39-52 Theory versus practice: a review of ‘willingness‐to‐pay’ in health and health care
by Jan Abel Olsen & Richard D. Smith - 53-66 Parameter solicitation for planning cost effectiveness studies with dichotomous outcomes
by Martin W. McIntosh & Scott D. Ramsey & Kristin Berry & Nicole Urban - 67-78 Preventable illness and out‐of‐area travel of children in New York counties
by Jayasree Basu & Bernard Friedman - 79-82 Economic evaluation alongside n‐of‐1 trials: getting closer to the margin
by Jonathan Karnon & Nawab Qizilbash - 83-84 International health care reform: a legal, economic and political analysis. Edited by C.M. Flood. Routledge, London (2000). 315 pages. ISBN 0 415 20844 0
by Gwyn Bevan - 84-84 Clinical governance in primary care. Edited by T. van Zwanenberg and J. Harrison. Radcliffe Press Ltd., (1999). 199 pages. ISBN 1 85775 3968
by Garry Barton - 85-86 The changing hospital industry: comparing not‐for‐profit and for‐profit institutions. Edited by David M. Cutler. Chicago University Press, Chicago (2000). 384 pages, US$53.00. ISBN 0 226 13219 6
by Peter C. Smith & Andrew Street - 86-86 The global challenge of health care rationing. Edited by A. Coulter and C. Ham. Open University Press, Buckingham (2000). 267 pages. ISBN 0 335 20463 5
by Ray Robinson - 86-87 Health reform: public success, private failure. Edited by Daniel Drache and Terry Sullivan. Routledge, London (1999). 366 pages. ISBN 0 415 20236 1
by Charles Normand - 87-88 Pricing life: the controversial role of cost‐effectiveness in health care. Edited by Peter A Ubel. MIT Press, Cambridge, MA (2000). xix+208 pages, £16.95. ISBN 0 262 21016 9
by Alan Williams - 88-89 Drugs dilemmas and choices by a working party of the Royal College of Psychiatrists and the Royal College of Physicians. Gaskell, London, UK (2000). 291 pages. ISBN 1 901242 44 7.. Drugs and the law: report of the independent inquiry into the Misuse of Drugs Act 1971 by The Police Foundation, London, UK (2000). 148 pages. ISBN 0 947692 47 9
by Christine Godfrey
December 2000, Volume 9, Issue 8
- 659-667 Health economists meet the fourth tempter: drug dependency and scientific discourse
by Steve Morgan & Morris Barer & Robert Evans - 669-680 Is there a trade‐off between longevity and quality of life in Grossman's pure investment model?
by Christoph Eisenring - 681-698 Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature
by Damian Walker & Julia A. Fox‐Rushby - 699-714 Cross‐subsidization in the market for employment‐related health insurance
by Alan C. Monheit & Thomas M. Selden - 715-726 Estimating the cost of primary care training in ambulatory settings
by Andrew J. Hogan & Luisa Franzini & James R. Boex - 727-728 Complete preferences over health states: a reply to the paper by Shiell et al
by Adam Oliver - 729-731 Will our understanding of completeness ever be complete?
by Alan Shiell & Penelope Hawe & Janelle Seymour - 733-738 Age and proximity to death as predictors of GP care costs: results from a study of nursing home patients
by Ciaran O'Neill & Lindsay Groom & Anthony J. Avery & Daphne Boot & Karine Thornhill - 739-740 In pursuit of an improving National Health Service edited by Alain C. Enthoven. The Nuffield Trust, London, 1999. No. of pages: 126. ISBN 1‐902089‐37‐5
by Ted Marmor - 740-741 Cost‐value analysis in health care: making sense out of QALYs by Eric Nord. Cambridge University Press, Cambridge, 1999. No. of pages: 157. ISBN 0 521 64434 8
by Alan Williams - 741-742 The politics of Medicare (2nd Edition) by Theodore R Marmor. Aldine de Gruyter, New York, 2000. No. of pages xii+228. ISBN 0 202 30425 6
by Martin Mckee
October 2000, Volume 9, Issue 7
- 565-566 Towards multidisciplinary research into health inequalities
by Adam Oliver & Richard Cookson - 567-568 Working together for equity
by Douglas Black - 569-570 Health inequalities: bringing the hidden assumptions into the open
by Rudolf Klein - 571-574 Equity in the allocation of health care resources
by Trevor A. Sheldon & Peter C. Smith - 575-579 Rationing for health equity: is it necessary?
by George Davey Smith & Stephen Frankel & Shah Ebrahim - 581-583 The need for an interdisciplinary perspective on the social determinants of health
by Richard G. Wilkinson - 585-586 Equity in health: a challenge for researchers and policy makers
by Alan Williams - 587-598 Interpreting the rational addiction model
by Brian S. Ferguson - 599-609 A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplasty
by Maiwenn J. Al & Ben A. Van Hout - 611-621 The social value of health programmes: is age a relevant factor?
by Eva Rodríguez & José Luis Pinto - 623-630 Definition, interpretation and calculation of cost‐effectiveness acceptability curves
by Mickael Löthgren & Niklas Zethraeus - 631-641 Institutional considerations in priority setting: transactions cost perspective on PBMA
by Stephen Jan - 643-657 The price of placements in residential and nursing home care: the effects of contracts and competition
by Julien Forder & Ann Netten
September 2000, Volume 9, Issue 6
- 463-464 Guest editors' introduction
by Andrew Jones & Owen O'Donnell - 465-474 Identifying demand for health resources using waiting times information
by Richard Blundell & Frank Windmeijer - 475-489 Estimates of use and costs of behavioural health care: a comparison of standard and finite mixture models
by Partha Deb & Ann M. Holmes - 491-511 The effect of smoking on health using a sequential self‐selection model
by Kajal Lahiri & Jae G. Song